The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 727 KB) and Technical Notes (PDF, 1.1 MB) pages.


Download and Print: Download Printer-friendly PDF Download data


Table 1.28

Age-Adjusted U.S. Death Rates and Trends for the Top 15 Cancer Sitesa
Females by Race/Ethnicity

Race/Ethnicity Primary Site Age-Adjusted Rateb,
2014-2018
Trend (APC)c,
2009-2018
All Races All Sites 133.5 -1.5*
Lung and Bronchus 32.0 -3.0*
Breast 20.1 -1.4*
Colon and Rectum 11.5 -2.0*
Pancreas 9.6 0.1
Ovary 6.7 -2.4*
Corpus and Uterus, NOS 4.9 2.0*
Leukemia 4.7 -1.8*
Non-Hodgkin Lymphoma 4.1 -2.6*
Liver & IBDf 4.0 1.9*
Brain and ONSf 3.6 0.4
Myeloma 2.6 -0.9*
Kidney and Renal Pelvis 2.3 -1.6*
Cervix Uteri 2.2 -0.5*
Stomach 2.2 -1.9*
Urinary Bladder 2.1 -0.6*
White All Sites 134.3 -1.4*
Lung and Bronchus 33.3 -2.8*
Breast 19.6 -1.4*
Colon and Rectum 11.3 -1.8*
Pancreas 9.5 0.2*
Ovary 6.9 -2.4*
Leukemia 4.9 -1.7*
Corpus and Uterus, NOS 4.5 1.9*
Non-Hodgkin Lymphoma 4.3 -2.6*
Brain and ONSf 3.9 0.5
Liver & IBDf 3.8 2.2*
Kidney and Renal Pelvis 2.3 -1.4*
Myeloma 2.3 -1.0*
Urinary Bladder 2.2 -0.4
Cervix Uteri 2.1 0.2
Stomach 1.9 -1.8*
Black All Sites 150.5 -1.7*
Lung and Bronchus 29.7 -3.3*
Breast 27.3 -1.5*
Colon and Rectum 14.8 -3.0*
Pancreas 12.0 -0.3
Corpus and Uterus, NOS 8.7 1.9*
Ovary 5.9 -2.2*
Myeloma 5.1 -1.0
Liver & IBDf 4.8 1.5*
Leukemia 4.3 -1.4*
Stomach 3.5 -3.5*
Cervix Uteri 3.3 -3.0*
Non-Hodgkin Lymphoma 3.1 -2.1*
Urinary Bladder 2.3 -1.3*
Brain and ONSf 2.3 1.0
Kidney and Renal Pelvis 2.2 -2.6*
Asian/
Pacific Islander
All Sites 84.6 -1.3*
Lung and Bronchus 16.3 -2.3*
Breast 11.7 0.6
Colon and Rectum 7.9 -2.6*
Pancreas 7.1 -0.7
Liver & IBDf 5.4 -2.3*
Ovary 4.4 -0.6
Stomach 4.0 -2.7*
Corpus and Uterus, NOS 3.2 2.3*
Non-Hodgkin Lymphoma 2.9 -2.8*
Leukemia 2.6 -3.2*
Brain and ONSf 1.9 1.6
Cervix Uteri 1.7 -0.7
Myeloma 1.3 0.0
Oral Cavity and Pharynx 1.1 -1.2
Kidney and Renal Pelvis 1.1 -2.1*
American Indian/
Alaska Natived
All Sites 120.1 -1.5*
Lung and Bronchus 27.4 -2.3*
Breast 14.8 0.3
Colon and Rectum 12.4 -2.7*
Pancreas 7.5 -0.3
Liver & IBDf 7.0 1.7
Ovary 6.0 -2.0
Corpus and Uterus, NOS 3.5 0.4
Stomach 3.5 -0.4
Non-Hodgkin Lymphoma 3.3 -2.4
Kidney and Renal Pelvis 3.2 -4.0*
Myeloma 3.1 1.4
Leukemia 2.8 -2.2
Cervix Uteri 2.4 -4.7*
Brain and ONSf 2.3 3.9
Urinary Bladder 1.7 -
Hispanice All Sites 94.6 -0.8*
Breast 13.8 -1.0*
Lung and Bronchus 12.3 -2.1*
Colon and Rectum 8.6 -1.8*
Pancreas 7.8 0.3
Liver & IBDf 6.0 1.1*
Ovary 5.1 -1.7*
Corpus and Uterus, NOS 4.1 2.4*
Stomach 3.9 -1.1*
Non-Hodgkin Lymphoma 3.7 -2.5*
Leukemia 3.6 -1.6*
Brain and ONSf 2.6 1.8*
Cervix Uteri 2.6 -0.9
Myeloma 2.2 -0.9
Kidney and Renal Pelvis 2.2 -1.0
Urinary Bladder 1.3 0.2

Footnotes:

Source: US Mortality Files, National Center for Health Statistics, Centers for Disease Control and Prevention.

a Top 15 cancer sites selected based on 2014-2018 age-adjusted rates for the race/ethnic group.

b Rates are per 100,000 and age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

c The APC is the Annual Percent Change over the time interval. Trends are based on rates age-adjusted to the 2000 US Std Population (19 age groups - Census P25-1130).

d Rates for American Indian/Alaska Native are based on the Purchased/Referred Care Delivery Area (PRCDA) counties.

e Hispanic is not mutually exclusive from whites, blacks, Asian/Pacific Islanders, and American Indians/Alaska Natives.

f IBD = Intrahepatic Bile Duct. ONS = Other Nervous System.

* The APC is significantly different from zero (p<.05).

- Statistic not shown. Rate based on less than 16 cases for the time interval. Trend based on less than 10 cases for at least one year within the time interval.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.